Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (331-340 of 632) with videos related to

Pageof 64
Sort By:
Journal of Hepatology|December 4, 2013
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patientsThomas Berg, Fabien Zoulim, Bernd Moeller, et al.
Frontiers in Transplantation|July 12, 2024
Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global surveyTommaso Di Maira, Carmen Vinaixa, Manhal Izzy, et al.
Journal of Hepatology|December 8, 2006
Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infectionEckart Schott, Heiko Witt, Holger Hinrichsen, et al.
Hepatology (Baltimore, Md.)|January 28, 2006
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II studyJohannes Wiegand, Peter Buggisch, Wulf Boecher, et al.
Clinical Chemistry and Laboratory Medicine|March 13, 2009
Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis?Jan Petrásek, Jaroslav A Hubácek, Felix Stickel, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 6, 2014
The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitisMaria Benito de Valle, Tobias Müller, Einar Björnsson, et al.
Annals of Hepatology|February 12, 2013
Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapyViola Knop, Gerlinde Teuber, Hartwig Klinker, et al.
Archives of Toxicology|July 9, 2021
Sex-dependent dynamics of metabolism in primary mouse hepatocytesLuise Hochmuth, Christiane Körner, Fritzi Ott, et al.
Hepatology (Baltimore, Md.)|January 2, 2010
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon systemPantxika Bellecave, Magdalena Sarasin-Filipowicz, Olivier Donzé, et al.
Hepatology (Baltimore, Md.)|August 24, 2005
Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infectionYves Horsmans, Thomas Berg, Jean-Pierre Desager, et al.
Pageof 64

Showing results (331-340 of 632) with videos related to

Sort By:
Pageof 64
Journal of Hepatology|December 4, 2013
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patientsThomas Berg, Fabien Zoulim, Bernd Moeller, et al.
Frontiers in Transplantation|July 12, 2024
Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global surveyTommaso Di Maira, Carmen Vinaixa, Manhal Izzy, et al.
Journal of Hepatology|December 8, 2006
Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infectionEckart Schott, Heiko Witt, Holger Hinrichsen, et al.
Hepatology (Baltimore, Md.)|January 28, 2006
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II studyJohannes Wiegand, Peter Buggisch, Wulf Boecher, et al.
Clinical Chemistry and Laboratory Medicine|March 13, 2009
Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis?Jan Petrásek, Jaroslav A Hubácek, Felix Stickel, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 6, 2014
The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitisMaria Benito de Valle, Tobias Müller, Einar Björnsson, et al.
Annals of Hepatology|February 12, 2013
Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapyViola Knop, Gerlinde Teuber, Hartwig Klinker, et al.
Archives of Toxicology|July 9, 2021
Sex-dependent dynamics of metabolism in primary mouse hepatocytesLuise Hochmuth, Christiane Körner, Fritzi Ott, et al.
Hepatology (Baltimore, Md.)|January 2, 2010
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon systemPantxika Bellecave, Magdalena Sarasin-Filipowicz, Olivier Donzé, et al.
Hepatology (Baltimore, Md.)|August 24, 2005
Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infectionYves Horsmans, Thomas Berg, Jean-Pierre Desager, et al.
Pageof 64